E128: Nerandomilast for Autoimmune ILD (FIBRONEER-ILD)

The Evidence Based Rheumatology Podcast by Michael Putman

Nov 12, 202519:03Health

Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been...

Related Episodes

Continue listening to more episodes from The Evidence Based Rheumatology Podcast.

E138: Dapirolizumab for SLE (PHOENYCS-GO)

Jul 24, 2026 - 22:09

A new therapy for SLE! This one is a CD40-CD40L blocker, which has some nice new-things to inhibit. The s...

E137: Obexelimab in IgG4-RD (INDIGO)

Jun 29, 2026 - 15:36

Another day, another B cell drug. This one adds an interesting option for IgG4-RD, offering a "maybe less...

E136: Secukinumab in PMR (REPLENISH)

Jun 15, 2026 - 13:39

Big trial this week in the NEJM investigating the IL17 inhibitor secukinumab in PMR. Well worth a read, I...

E135: IL17 and a GLP1?

Apr 30, 2026 - 11:03

Really interesting study this week comparing the IL17 inhibitor ixekizumab WITH the GLP1 inhibitor tirzep...

E134: Brepocitinib in Dermatomyositis (VALOR)

Apr 17, 2026 - 14:58

Great trial this week looking at brepocitinib in dermatomyositis. Looks like a winner, expect it will be...

E133: Obinutuzumab for SLE (ALLEGORY)

Mar 19, 2026 - 15:21

Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newslett...

E132: Romosozumab vs teriparatide for osteoproosis (STRUCTURE)

Mar 5, 2026 - 13:54

Quick podcast this week about a nifty head to head study that I had previously missed. Worth reading if -...

E131: A Sham-Controlled Sham of a Trial: RESET-RA

Jan 21, 2026 - 14:48

Today I cover the recent publication of the RESET-RA study, which evaluated vagal nerve stimulation to tr...